Karyopharm Therapeutics reports mixed Q2 results; reaffirms FY26 outlook
Karyopharm (KPTI) Q2 results: GAAP EPS -$2.32 miss, revenue $33.43M beats (-11.9% Y/Y), cash $65.4M.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Karyopharm (KPTI) Q2 results: GAAP EPS -$2.32 miss, revenue $33.43M beats (-11.9% Y/Y), cash $65.4M.
Karyopharm Therapeutics reports mixed Q2 results; reaffirms FY26 outlook | Seeking Alpha
Karyopharm Therapeutics
press release
(
KPTI
): Q2 GAAP EPS of -$2.32
misses by $0.90
.
Revenue of $33.43M (-11.9% Y/Y)
beats by $1.21M
.
Cash position: Cash, cash equivalents, restricted cash and investments as of June 30, 2026, totaled $65.4 million.
The company
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
TTEC Secures $21M IRS Contact Center Contract, Bolstering Government Services Growth
TTEC wins a $21 million IRS contact center contract, strengthening its government services segment. This analysis covers the deal's significance, industry trends, and potential impact on the stock, highlighting TTEC's competitive position in the public sector outsourcing market.
Bending Spoons Q1 Earnings Beat: Non-GAAP EPS $0.46, Revenue $704M, AI-Driven Growth
Bending Spoons reported Q1 earnings with Non-GAAP EPS of $0.46 beating estimates by $0.19, and revenue of $704 million surpassing expectations by $21.37 million. AI applications and acquisition integration fuel growth, but competition and integration risks remain.
Comscore outlines $20M-$25M annual run-rate cost savings as it forecasts $315M-$325M 2026 revenue (NASDAQ:SCOR)
comScore (SCOR) Q2 2026 earnings call: Movies divestiture, $40M debt payoff, new ROI strategy, and 2026 guidance.
European shares tick higher as crude prices ease, most regional sectors in green (EUR:USD:)
European markets update: Stoxx 600 edges up as oil slides on demand worries; UK GDP rises 0.4%.
